International
Conference

"Lung Regeneration and Beyond –
BREATH meets REBIRTH"

Thursday, July 7, 2016

17.30 - 18.30	Registration

	KEYNOTE LECTURE:
18.30 - 19.30	"The past: The renaissance of bronchiectasis"
	Robert Wilson (London, UK)
	(with introduction by Tobias Welte)

19.30 - 20.00	A patient´s perspective
	Marta Almagro (Barcelona, Spain)

20.00	DINNER at conference venue

Friday, July 8, 2016

Session I (Morning) - Clinical trials and challenges in bronchiectasis

Chairs: Tobias Welte (Hannover, Germany) and Montserrat Vendrell (Giron, Spain)

9.00 - 9.30	"Inhaled antibiotics: potential and pitfalls"
	Alan Barker (Oregon, USA)

	Oral Presentation
9.30 - 9.50	"12-Month Follow-up from Phase 2 Trail of Liposomal Amikacin for Inhalation (LAI) in Patients With Nontuberculous Mycobacterial (NTM) Lung Infection"
	David Griffith (Texas, USA)

9.50 - 10.20	"Macrolides: known knowns, and known unknowns"
	Conroy Wong (Auckland, New Zealand)

	Oral Presentation
10.20 - 10.40	"The relationship between serum- and sputum levels of azithromycin and clinical endpoints in bronchiectasis patients in bronchiectasis patients using maintenance treatment"
	Josje Altenburg (Alkmaar, The Netherlands)

10.40 - 11.00	COFFEE BREAK

11.00 - 11.30	"Quality of life as an outcome measure in clinical trials!"
	Alexandra Quittner (Miami, USA)

11.30 - 12.00	"Lost in translation? Therapeutic contrasts in CF and non-CF bronchiectasis"
	Lieven Dupont (Leuven, Belgium)

	Oral Presentation
12.00 - 12.20	"Risk factors for bronchiectasis exacerbations caused by multidrug-resistant microorganisms"
	Rosario Menéndez (Valencia, Spain)

12.20 - 13.20	LUNCH BREAK and POSTER WALK

Friday, July 8, 2016

Session II (Afternoon) - Advances in microbiology in bronchiectasis

Chairs: Michael Loebinger (London, UK) and Antoni Torres (Barcelona, Spain)

13.20 - 13.50	"Introducing the micorbiome, lesson from the healthy lung and CF"
	Michael Surette (Calgary, Canada)

	Oral Presentation
13.50 - 14.10	"Pseudomonas aeruginosa diversity and adaption in the non-Cystic Fibrosis bronchiectasis lung"
	Anthony De Soyza (Newcastle upon Tyne, UK)

14.10 - 14.40	"Microbiota composition and disease severity in bronchiectasis"
	Geraint Rogers (Adelaide, Australia)

14.40 - 15.00	COFFEE BREAK

15.00 - 15.30	"Molecular diagnosis of infection and resistance"
	Stuart Elborn (Belfast, UK)

	Oral Presentation
15.30 - 15.50	"Prevalence of Nuntuberculous Mycobacterial Pulmonary Disease, Germany 2009-2014"
	Jessica Rademacher (Hannover, Germany)

15.50 - 16.20	"Understanding the role of NTM"
	Andres Floto (Cambridge, UK)

16.20 - 17.30	POSTER SESSION

	KEYNOTE LECTURE:
17:30 - 18.30	"The Present: Bronchiectasis in 2016"
	Anne O´Donnell (Georgetown, USA)


19.30	CONFERENCE DINNER (at Hugo´s, Hannover city center)

Saturday, July 9, 2016

Session III (Morning) - Understanding inflammation and anti-inflammatory approaches

Chairs: Timothy Aksamit (USA) and Francesco Blasi (Italy)

8.30 -9.00	"Non-CF Bronchiectasis: a spectrum of CFTR dysfunction?"
	Felix C. Ringshausen (Hannover, Germany)

	Oral Presentation
9.00 - 9.20	"Bronchiectasis with upper airways symptoms is associated with allergic features and frequent exacerbations"
	Michal Shteinberg (Haifa, Israel)

9.20 - 9.50	"Omics approaches to understand airway inflammation in bronchiectasis"
	James Chalmers (Dundee, UK)

	Oral Presentation
9.50 - 10.10	"Pneumonic vs. non-pneumonic exacerbations in bronchiectasis"
	Edmundo Rosales-Mayor (Barcelona, Spain)

10.10 - 10.30	COFFEE BREAK

	Oral Presentation
10.30 - 10.50	"Anti-Pseudomonas aeruginosa IgG Antibodies and Chronic Airway Infection in Non-Cystic Fibrosis bronchiectasis"
	Guillermo Suarez-Cuartin (Barcelona, Spain)

10.50 - 11.20	"Infection or inflammation: Chicken or egg - implications for treatment"
	Gregory Tino (Pennsylvania, USA)

11.20 - 11.50	Report from the EMBARC/BRR working group on bronchiectasis outcomes definition
	Tim Aksamit (Minnesota, USA), Charles S. Haworth (Cambridge, UK), Adam Hill (Edinburgh, UK)

Saturday, July 9, 2016

Session IV (Afternoon) - Asthma and COPD/bronchiectasis overlap

Chairs: Eva Polverino (Spain) and Michal Shteinberg (Israel)

11.50 -12.20	"Asthma and bronchiectasis"
	Eva Polverino (Barcelona, Spain)

12.20 -13.00	LUNCH BREAK

13.00 -13.30	"COPD and bronchiectasis - a real phenotype?"
	John Hurst (London, UK)

13.30 - 14.00	"Translating treatments between COPD and bronchiectasis"
	Menno van der Eerden (Rotterdam, The Netherlands)

14.00 - 15.00	KEYNOTE LECTURE:
	"The Future: what is next in bronchiectasis?"
	Anthony De Soyza (Newcastle upon Tyne, UK)

15.00 - 15.30	Conference Wrap-up
	from patients' perspective
	Marta Almagro and Thomas F. Ruddy
	(Spain and US/Germany)

15.30	Meeting closure